The same MLD group was also tested for ChT levels in CSF in our previous study, compared to our GD1 patients where CSF was available, demonstrating that ChT levels exhibited a higher increase in the MLD group compared to the GD group, although they were not statistically different. The gene discussed is SLC5A7; the disease is metachromatic leukodystrophy.